Cibus (CBUS) Stock Price, News & Analysis

Company Overview

Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.

Key Stats

• Today's Range: $1.53 to $1.61
• 50-Day Range: $1.55 to $3.36
• 52-Week Range: $1.40 to $10.77
• Volume: 370,486 shs
• Average Volume: 213,241 shs
• Market Capitalization: $52.25 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $22.00
• Consensus Rating: Buy

Cibus Stock Analysis - MarketRank™

Cibus scored higher than 53% of companies evaluated by MarketBeat, and ranked 94th out of 155 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Buy

Consensus Rating

Cibus has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Cibus has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Cibus are expected to decrease in the coming year, from ($2.96) to ($3.02) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cibus is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cibus is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Cibus has a P/B Ratio of 0.13. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.16% of the float of Cibus has been sold short.

Short Interest Ratio / Days to Cover

Cibus has a short interest ratio ("days to cover") of 6.3.

Change versus previous month

Short interest in Cibus has recently decreased by 24.57%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cibus does not currently pay a dividend.

Dividend Growth

Cibus does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

5.16% of the float of Cibus has been sold short.

Short Interest Ratio / Days to Cover

Cibus has a short interest ratio ("days to cover") of 6.3.

Change versus previous month

Short interest in Cibus has recently decreased by 24.57%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.54

News Sentiment

Cibus has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 12 news articles for Cibus this week, compared to 3 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cibus insiders have not sold or bought any company stock.

Percentage Held by Insiders

31.16% of the stock of Cibus is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 33.81% of the stock of Cibus is held by institutions.

CBUS Stock Analysis - Frequently Asked Questions

How have CBUS shares performed this year?

Cibus' stock was trading at $2.78 at the beginning of 2025. Since then, CBUS shares have decreased by 42.4% and is now trading at $1.60.
View the best growth stocks for 2025 here.

How were Cibus' earnings last quarter?

Cibus, Inc. (NASDAQ:CBUS) released its earnings results on Thursday, May, 8th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.70) by $0.04. The company had revenue of $1.03 million for the quarter, compared to the consensus estimate of $1.15 million. Cibus had a negative trailing twelve-month return on equity of 28.17% and a negative net margin of 10,724.78%.

When did Cibus IPO?

Cibus (CBUS) raised $100 million in an initial public offering on Thursday, February 14th 2019. The company issued 6,700,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Piper Jaffray acted as the underwriters for the IPO.

Who are Cibus' major shareholders?

Top institutional investors of Cibus include Armistice Capital LLC (5.93%), Certior Financial Group LLC (0.45%), Charles Schwab Investment Management Inc. (0.17%) and Goldman Sachs Group Inc. (0.15%). Insiders that own company stock include Gregory Francis William Gocal, Carlo Broos and Gerhard Prante.
View institutional ownership trends.

How do I buy shares of Cibus?

Shares of CBUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cibus own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cibus investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Advanced Micro Devices (AMD), Visa (V), Netflix (nflx) and JPMorgan Chase & Co. (JPM).

Company Calendar

• Last Earnings: 5/08/2025
• Today: 6/13/2025
• Next Earnings (Estimated): 8/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: Agricultural chemicals
• Sub-Industry: Chemicals
• Current Symbol: NASDAQ:CBUS
• CIK: 1705843
• Web: www.calyxt.com
• Phone: (858) 450-0008
• Fax: N/A
• Employees: 48
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $22.00
• High Stock Price Target: $25.00
• Low Stock Price Target: $17.50
• Potential Upside/Downside: +1,275.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($10.98)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$267.64 million
• Net Margins: -10,724.78%
• Pretax Margin: -12,860.54%
• Return on Equity: -28.17%
• Return on Assets: -13.39%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.44
• Quick Ratio: 1.44

Sales & Book Value

• Annual Sales: $4.75 million
• Price / Sales: 11.00
• Cash Flow: $5.71 per share
• Price / Cash Flow: 0.28
• Book Value: $12.38 per share
• Price / Book: 0.13

Miscellaneous

• Outstanding Shares: 32,658,000
• Free Float: 13,387,000
• Market Cap: $52.25 million
• Optionable: Optionable
• Beta: 1.88